HIF-1alpha is essential for myeloid cell-mediated inflammation
about
Oxidation in rheumatoid arthritis.miR-17-92 expression in differentiated T cells - implications for cancer immunotherapyHyperbaric treatment for children with autism: a multicenter, randomized, double-blind, controlled trialThe streptococcal collagen-like protein-1 (Scl1) is a significant determinant for biofilm formation by group a StreptococcusThe group A streptococcal collagen-like protein-1, Scl1, mediates biofilm formation by targeting the extra domain A-containing variant of cellular fibronectin expressed in wounded tissueUbiquitin-specific protease 19 (USP19) regulates hypoxia-inducible factor 1α (HIF-1α) during hypoxiaMint3 enhances the activity of hypoxia-inducible factor-1 (HIF-1) in macrophages by suppressing the activity of factor inhibiting HIF-1Endothelial catabolism of extracellular adenosine during hypoxia: the role of surface adenosine deaminase and CD26SENP3 is responsible for HIF-1 transactivation under mild oxidative stress via p300 de-SUMOylationSystemic VHL gene functions and the VHL diseaseHypoxia-inducible factors and the response to hypoxic stressDeletion of vascular endothelial growth factor in myeloid cells accelerates tumorigenesisMicroRNAs in immune regulation--opportunities for cancer immunotherapyTreating lung inflammation with agonists of the adenosine A2A receptor: promises, problems and potential solutionsRegulation of type II collagen synthesis during osteoarthritis by prolyl-4-hydroxylases: possible influence of low oxygen levelsMyeloid progenitors differentiate into microglia and promote vascular repair in a model of ischemic retinopathyCoordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptorsOxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammationHypoxia: not merely a regulator of angiogenesis?Loss of skeletal muscle HIF-1alpha results in altered exercise enduranceImmunobiology of hepatocarcinogenesis: Ways to go or almost there?Hypoxia-Inducible Factor (HIF) as a Target for Novel Therapies in Rheumatoid ArthritisSickness-Associated Anorexia: Mother Nature's Idea of Immunonutrition?Hypoxia and its implications in rheumatoid arthritisHallmarks of cancer and AU-rich elementsGlucose Metabolism in T Cells and Monocytes: New Perspectives in HIV PathogenesisModulation of Host Angiogenesis as a Microbial Survival Strategy and Therapeutic TargetThe Response of Macrophages and Neutrophils to Hypoxia in the Context of Cancer and Other Inflammatory DiseasesA Metabolic Immune Checkpoint: Adenosine in Tumor MicroenvironmentHypoxia-inducible factors as molecular targets for liver diseasesNF-κB and HIF crosstalk in immune responsesExploring the HIFs, buts and maybes of hypoxia signalling in disease: lessons from zebrafish modelsPathogenesis of Myeloproliferative Neoplasms: Role and Mechanisms of Chronic InflammationControl of macrophage metabolism and activation by mTOR and Akt signalingBench-to-bedside review: the effects of hyperoxia during critical illnessRegulating the Intersection of Metabolism and Pathogenesis in Gram-positive BacteriaComplement and macrophage crosstalk during process of angiogenesis in tumor progressionExtrinsic and intrinsic control of macrophage inflammatory responsesDrosophila blood as a model system for stress sensing mechanismsRedox regulation of stem/progenitor cells and bone marrow niche
P2860
Q21195671-3B6DE702-0D42-402F-9517-57AA01110542Q21245464-F8AEB6C9-B2DA-4040-A80B-F2482C0D1C15Q21260340-EAD787F3-363E-4BD9-88B9-9805A53E504CQ23913487-EF5D862E-A3A9-449D-8306-2351D5FC4679Q23913488-C4AF35BE-AC2D-4999-9304-70F2BA77203CQ24298656-60C676FF-B460-4E3D-82CC-75686BCE9256Q24312373-2A2D67FC-A68B-4B2C-BCD6-58A13492EDA1Q24323818-E68E56F1-5238-43B7-9A90-A45E23F47B58Q24328747-CDD45C1D-83D3-4312-98E8-7E59DC616E99Q24605882-FE00860C-2D3A-4D9A-BC8A-C6D2926942D8Q24629323-B3A8240A-9E6A-4455-812A-47AD68D668CDQ24630255-6B5117CA-3648-4238-8075-52BABCECC149Q24631617-73D1AFEF-CBED-4856-8BD5-E85F10783412Q24644038-7409356F-AB0D-4BA0-8D4A-A667C22B0267Q24671477-37820374-B901-4BE8-8C7C-B3E4F8075F5AQ24672544-C38E7709-AA09-4F7C-B138-FB35D74C29FDQ24672615-45ECBA6C-7ADE-4E0C-B302-46DBD9EEA909Q24682128-84C9AC47-4AE0-4EF2-85AB-8DCF1BFED682Q24793753-1C193F73-2BF9-4550-8235-49A738ADA87FQ24801269-21C29EB9-1BCC-423E-987C-ECB4430899BDQ26738293-56048AE2-A2A3-45CA-A64F-BAC1690603DFQ26738338-29BA0109-C6EF-4C86-AF43-14FC9E300945Q26738529-E881F73A-4464-4603-9EAE-859691A32D79Q26739909-0FC023A9-84B2-48E3-BA17-42E129B8AF4AQ26744134-BE89B97F-DCAD-4618-B1B4-54662F0991D6Q26747110-76380E38-82B4-45F9-9C2D-17B2D91BC7C1Q26748251-BDD80596-2B01-4793-AF61-DA60DDD45349Q26749138-D8A71856-F892-4584-813C-C0C65B0E6F61Q26749571-1AFA209B-7255-4D6A-8A74-F817652EF486Q26752304-B9A9D870-5F9C-4163-AF1D-C2520BA52EBCQ26777974-DC0097EB-BB25-42D1-8DDD-C85BFD1EC95EQ26778116-15943B8F-38D8-46FD-85BF-A38507FFC0D2Q26779960-60689B36-6F3E-4138-AD7E-CC34DD6F8210Q26781587-EC5DDC97-6469-44D9-AADF-8B56677939AAQ26798077-0689EF84-7899-4E8C-8212-61488C4F4275Q26799806-F6B683F0-BC6C-4CAD-871F-DDDA73B97D1DQ26801339-10CAEE1A-2E97-4991-80FD-19647D31EEB7Q26822651-746E63CA-3FBF-47ED-8905-9DD4A6268EC5Q26827120-746034FF-9ED6-411D-91CF-87A95177BB53Q26851313-4558789C-0A0D-45FB-899B-1070A3EEBFCF
P2860
HIF-1alpha is essential for myeloid cell-mediated inflammation
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
HIF-1alpha is essential for myeloid cell-mediated inflammation
@ast
HIF-1alpha is essential for myeloid cell-mediated inflammation
@en
type
label
HIF-1alpha is essential for myeloid cell-mediated inflammation
@ast
HIF-1alpha is essential for myeloid cell-mediated inflammation
@en
prefLabel
HIF-1alpha is essential for myeloid cell-mediated inflammation
@ast
HIF-1alpha is essential for myeloid cell-mediated inflammation
@en
P2093
P2860
P3181
P1433
P1476
HIF-1alpha is essential for myeloid cell-mediated inflammation
@en
P2093
Clausen BE
Firestein GS
Jaenisch R
Johnson RS
P2860
P304
P3181
P356
10.1016/S0092-8674(03)00154-5
P407
P577
2003-03-07T00:00:00Z